CNSP (CNS Pharmaceuticals) GF Score: 30/100 (As of Jul. 11, 2026) — Near Median


CNSP CNS Pharmaceuticals Inc CNSP
30 GF Score
Price $5.17
! 1 Warning Sign
View Full Analysis

What is CNS Pharmaceuticals GF Score?

CNS Pharmaceuticals CNSP -2.91% 30 GF Score is 30 as of Jul. 11, 2026, which is 7% above its 10-year median of 28.00. GuruFocus rates CNSP with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

CNS Pharmaceuticals has the GF Score of 30, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 6/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes CNS Pharmaceuticals might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

CNS Pharmaceuticals  (NAS:CNSP) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

CNS Pharmaceuticals GF Score Related Terms

CNSP vs NXTC, ENVB, CDIO: GF Score Comparison

For the Biotechnology subindustry, CNS Pharmaceuticals's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNS Pharmaceuticals GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNS Pharmaceuticals's GF Score distribution charts can be found below:

* The bar in red indicates where CNS Pharmaceuticals's GF Score falls into.


CNSP
30GF Score
CNS Pharmaceuticals Inc CNSP
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 30 mean?
CNS Pharmaceuticals (CNSP) has a GF Score of 30 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on CNS Pharmaceuticals and its competitors. This is near median its historical median of 28.00. Over the past decade, CNS Pharmaceuticals' GF Score has ranged from 16.00 to 40.00.
Is CNS Pharmaceuticals' GF Score too high?
CNS Pharmaceuticals' current GF Score of 30 is near median its 10-year median of 28.00. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 40.00. Overall, CNS Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does CNS Pharmaceuticals' GF Score compare to NXTC and ENVB?
CNS Pharmaceuticals' GF Score of 30 can be compared against companies in the Biotechnology industry. Historically, CNS Pharmaceuticals' own GF Score has ranged from 16.00 to 40.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on CNS Pharmaceuticals and its competitors. CNS Pharmaceuticals's current GF Score is 30, which is near median its own 10-year median of 28.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Pharmaceuticals stock overvalued right now?
CNS Pharmaceuticals (CNSP) has a current GF Score of 30. The current GF Score is 30, which is near median its 10-year median of 28.00. CNS Pharmaceuticals' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For CNS Pharmaceuticals (CNSP), the current GF Score is 30 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CNS Pharmaceuticals Business Description

Address 2100 West Loop South, Suite 900, Houston, TX, USA, 77027
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
30GF Score

Get the complete analysis for CNSP

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.17
Price